Bimekizumab

From WikiMD's Wellness Encyclopedia

Bimekizumab
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 1418205-77-2
PubChem
DrugBank
ChemSpider
KEGG D11550


Bimekizumab (INN[1]) is a monoclonal antibody that is being investigated for ankylosing spondylitis and psoriasis.

This drug is being developed by UCB. As of 2018

, bimekizumab is undergoing Phase III trials.

References[edit | edit source]

  1. World Health Organization, International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 110, WHO Drug Information, 2013, Vol. 27(Issue: 4), Full text,
Inmunoglobulina.png
   This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!


Medicine-stub.png
This article is a stub related to medicine. You can help WikiMD by expanding it!
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD